|
 |
| LETTER TO EDITOR |
|
| Year : 2011 | Volume
: 32
| Issue : 3 | Page : 432 |
|
|
Mehamudgaravati and type 2 diabetes mellitus
Viroj Wiwanitkit
Visiting Professor, Hainan Medical University, China; Wiwanitkit House, Bangkhae, Bangkok, Thailand 10160
| Date of Web Publication | 17-Mar-2012 |
Correspondence Address:
Viroj Wiwanitkit
Visiting Professor, Hainan Medical University, China; Wiwanitkit House, Bangkhae, Bangkok, Thailand 10160
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-8520.93929
How to cite this article:
Wiwanitkit V. Mehamudgaravati and type 2 diabetes mellitus. AYU 2011;32:432 |
Sir,
The recent publication on Mehamudgaravati and type 2 diabetes mellitus is very interesting. [1] Tanna et al., concluded that this drug is useful due to "its known hypolipidemic, hypocholesterolemic, hepatoprotective, antihyperglycemic, antistress, antioxidant and immunomodulatory activities. [1]" I have some comments on this work. First, the authors tried to investigate on some parameters. Many parameters are subjective and can be biased. Focussing on laboratory investigation, there is no quality control information. The simple fasting blood sugar can be affected by several interferences and a single measurement might not be a reliable parameter for decision on improvement of diabetes mellitus. Finally, the authors did not investigate on lipid, antioxidant and immunity; hence, the conclusion on those aspects cannot be made.
 References | |  |
| 1. | Tanna I, Chandola HM, Joshi JR. Clinical efficacy of Mehamudgaravati in type 2 diabetes mellitus. Ayu 2011;32:30-9. 
 |
|
